Cannabis - South Korea

  • South Korea
  • South Korea is projected to reach a revenue of US$460.80m in the Cannabis market by 2024.
  • The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 2.75%, leading to a market volume of US$527.80m by 2029.
  • When compared globally, the United States is expected to generate the most revenue, reaching US$42.98bn in 2024.
  • In terms of per person revenues in 2024, US$70.39 are generated concerning the total population figures.
  • South Korea's evolving regulatory landscape is shaping a burgeoning cannabis market with a focus on research and pharmaceutical advancements.

Key regions: United States, Canada, Netherlands, Germany, Thailand

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cannabis market in South Korea has been experiencing significant growth and development in recent years.

Customer preferences:
South Korean consumers are increasingly seeking out alternative health and wellness products, leading to a growing interest in cannabis-based products. The shift towards more natural and holistic remedies has driven demand for CBD products in particular.

Trends in the market:
One notable trend in the South Korean Cannabis market is the rising popularity of beauty and skincare products infused with CBD. As South Korea is known for its innovative skincare industry, the incorporation of CBD into beauty products has resonated well with consumers looking for new and effective solutions.

Local special circumstances:
In South Korea, the regulatory environment around cannabis remains strict, with recreational use being illegal. However, the government has taken steps to legalize medical cannabis under certain conditions, paving the way for the growth of the market. This unique regulatory landscape has created opportunities for companies to enter the market with medical cannabis products.

Underlying macroeconomic factors:
The growing acceptance of CBD products in South Korea is also influenced by broader global trends towards cannabis legalization and destigmatization. As more countries around the world embrace the medicinal benefits of cannabis, South Korea is following suit, albeit with caution and regulation in place. This alignment with global attitudes towards cannabis is shaping the market landscape in the country.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Users
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)